Cognitive Trajectories in Older Patients with Cancer Undergoing Radiotherapy-A Prospective Observational Study
- PMID: 35877269
- PMCID: PMC9317354
- DOI: 10.3390/curroncol29070409
Cognitive Trajectories in Older Patients with Cancer Undergoing Radiotherapy-A Prospective Observational Study
Abstract
Cognitive function can be affected by cancer and/or its treatment, and older patients are at a particular risk. In a prospective observational study including patients ≥65 years referred for radiotherapy (RT), we aimed to investigate the association between patient- and cancer-related factors and cognitive function, as evaluated by the Montreal Cognitive Assessment (MoCA), and sought to identify groups with distinct MoCA trajectories. The MoCA was performed at baseline (T0), RT completion (T1), and 8 (T2) and 16 (T3) weeks later, with scores ranging between 0 and 30 and higher scores indicating better function. Linear regression and growth mixture models were estimated to assess associations and to identify groups with distinct MoCA trajectories, respectively. Among 298 patients with a mean age of 73.6 years (SD 6.3), the baseline mean MoCA score was 24.0 (SD 3.7). Compared to Norwegian norm data, 37.9% had cognitive impairment. Compromised cognition was independently associated with older age, lower education, and physical impairments. Four groups with distinct trajectories were identified: the very poor (6.4%), poor (8.1%), fair (37.9%), and good (47.7%) groups. The MoCA trajectories were mainly stable. We conclude that cognitive impairment was frequent but, for most patients, was not affected by RT. For older patients with cancer, and in particular for those with physical impairments, we recommend an assessment of cognitive function.
Trial registration: ClinicalTrials.gov NCT03071640.
Keywords: Montreal Cognitive Assessment; cancer-related cognitive impairment; cognitive function; frailty; geriatric oncology; physical impairment.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
The prevalence and impact of undiagnosed cognitive impairment in older vascular surgical patients.J Vasc Surg. 2014 Oct;60(4):1002-11.e3. doi: 10.1016/j.jvs.2014.04.041. Epub 2014 Jul 11. J Vasc Surg. 2014. PMID: 25017513
-
Trajectories of cognitive performance over five years in a prospective cohort of patients with breast cancer (NEON-BC).Breast. 2021 Aug;58:130-137. doi: 10.1016/j.breast.2021.05.006. Epub 2021 May 15. Breast. 2021. PMID: 34023557 Free PMC article.
-
Prospective comparison of the Montreal Cognitive Assessment (MoCA) and the Mini Mental State Examination (MMSE) in geriatric oncology.J Geriatr Oncol. 2019 Mar;10(2):235-240. doi: 10.1016/j.jgo.2018.08.003. Epub 2018 Aug 24. J Geriatr Oncol. 2019. PMID: 30150019
-
Influence of Frailty on Cognitive Decline: A Population-Based Cohort Study in Rural Ecuador.J Am Med Dir Assoc. 2019 Feb;20(2):213-216. doi: 10.1016/j.jamda.2018.09.023. Epub 2018 Nov 16. J Am Med Dir Assoc. 2019. PMID: 30455048
-
Association Between Neurocognitive Decline and Visual Field Variability in Glaucoma.JAMA Ophthalmol. 2017 Jul 1;135(7):734-739. doi: 10.1001/jamaophthalmol.2017.1279. JAMA Ophthalmol. 2017. PMID: 28520873 Free PMC article.
Cited by
-
Remote assessment of cognition and quality of life following radiotherapy for nasopharyngeal carcinoma: deep-learning-based predictive models and MRI correlates.J Cancer Surviv. 2024 Aug;18(4):1297-1308. doi: 10.1007/s11764-023-01371-8. Epub 2023 Apr 3. J Cancer Surviv. 2024. PMID: 37010777 Free PMC article.
-
Evaluating the Effectiveness of Visuospatial Memory Stimulation Using Virtual Reality in Head and Neck Cancer Patients-Pilot Study.Cancers (Basel). 2023 Mar 7;15(6):1639. doi: 10.3390/cancers15061639. Cancers (Basel). 2023. PMID: 36980525 Free PMC article.
References
-
- Mohile S.G., Mohamed M.R., Xu H., Culakova E., Loh K.P., Magnuson A., Flannery M.A., Obrecht S., Gilmore N., Ramsdale E., et al. Evaluation of geriatric assessment and management on the toxic effects of cancer treatment (GAP70+): A cluster-randomised study. Lancet. 2021;398:1894–1904. doi: 10.1016/S0140-6736(21)01789-X. - DOI - PMC - PubMed
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Medical